Passive

Vanguard Health Care Index Fund

The Fund seeks to track the performance of a benchmark index that measures the investment return of health care stocks.

$250.27

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Health Care Index Fund VHT
Fund Size
$19.8 Billion
Dividend
1.6%
Fees
0.10%
Total Stock Market Index Fund VTSAX
Fund Size
$1.7 Trillion
Dividend
-
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.7 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VFIAX
Fund Size
$1.32 Trillion
Dividend
-
Fees
-
500 Index Fund VFINX
Fund Size
$1.32 Trillion
Dividend
-
Fees
-
View 1311 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $218 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.6 %
Beta Indicates the relationship between the price performance of a share and the market. 0.6772
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 38.56
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -60.37
Profitable Companies 88
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 7404.39
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.54
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 9.83
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 47.88
Enterprise Value to Revenue Enterprise value divided by revenue -6836.95
Total Debt to Enterprise Value Total debt divided by enterprise value 0.12
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -781.09%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 132.12%
Return on Assets Indicates a company's profitability in relation to its total assets. 12.09%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 23.53%

Industries

Healthcare 77.1%
Other 6.8%
Industrials 2.6%
Technology 2.4%
Finance 1.9%
Consumer Staples 0.5%
Consumer Discretionary 0.5%
Materials 0.2%
N/A 8.0%

Market cap

Micro Cap 0%
Small Cap 2%
Mid Cap 6%
Large Cap 57%
Mega Cap 35%

424 Investments

P/E-Ratio
Total Investment
Weight
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
66.3
Total Investment
$2.36 Billion
Weight
11.9%
UnitedHealth Group Inc logo

UNH - Finance and Insurance

UnitedHealth Group Inc

P/E-Ratio
13.0
Total Investment
$1.39 Billion
Weight
7.0%
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
80.5
Total Investment
$1.06 Billion
Weight
5.3%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
17.3
Total Investment
$940 Million
Weight
4.7%
Abbott Laboratories logo

ABT - Manufacturing

Abbott Laboratories

P/E-Ratio
17.5
Total Investment
$763 Million
Weight
3.8%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
11.9
Total Investment
$708 Million
Weight
3.6%
Intuitive Surgical Inc logo

ISRG - Manufacturing

Intuitive Surgical Inc

P/E-Ratio
73.9
Total Investment
$647 Million
Weight
3.3%
Thermo Fisher Scientific Inc logo

TMO - Professional, Scientific, and Technical Services

Thermo Fisher Scientific Inc

P/E-Ratio
23.4
Total Investment
$642 Million
Weight
3.2%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
26.8
Total Investment
$526 Million
Weight
2.7%
Boston Scientific Corp logo

BSX - Manufacturing

Boston Scientific Corp

P/E-Ratio
72.5
Total Investment
$486 Million
Weight
2.5%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
17.7
Total Investment
$476 Million
Weight
2.4%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
23.0
Total Investment
$452 Million
Weight
2.3%
Danaher Corp logo

DHR - Manufacturing

Danaher Corp

P/E-Ratio
38.2
Total Investment
$429 Million
Weight
2.2%
Vanguard Cmt Funds-Vanguard Market Liquidity Fund logo

Vanguard Cmt Funds-Vanguard Market Liquidity Fund

P/E-Ratio
n/a
Total Investment
$428 Million
Weight
2.2%
Stryker Corp logo

SYK - Manufacturing

Stryker Corp

P/E-Ratio
50.4
Total Investment
$421 Million
Weight
2.1%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
-118.3
Total Investment
$394 Million
Weight
2.0%
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
-16.7
Total Investment
$384 Million
Weight
1.9%
Medtronic PLC logo

Medtronic PLC

P/E-Ratio
n/a
Total Investment
$375 Million
Weight
1.9%
Elevance Health Inc logo

ANTM - Finance and Insurance

Elevance Health Inc

P/E-Ratio
14.7
Total Investment
$292 Million
Weight
1.5%
Cigna Group/The logo

CI - Finance and Insurance

Cigna Group/The

P/E-Ratio
17.7
Total Investment
$274 Million
Weight
1.4%
McKesson Corp logo

MCK - Wholesale Trade

McKesson Corp

P/E-Ratio
27.7
Total Investment
$264 Million
Weight
1.3%
CVS Health Corp logo

CVS - Retail Trade

CVS Health Corp

P/E-Ratio
16.1
Total Investment
$263 Million
Weight
1.3%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
29.2
Total Investment
$241 Million
Weight
1.2%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
12.6
Total Investment
$241 Million
Weight
1.2%
Becton Dickinson & Co logo

BDX - Manufacturing

Becton Dickinson & Co

P/E-Ratio
33.2
Total Investment
$207 Million
Weight
1.0%